Quest Diagnostics Other Non-Cash Items 2010-2025 | DGX

Quest Diagnostics annual/quarterly other non-cash items history and growth rate from 2010 to 2025. Other non-cash items can be defined as miscellaneous non-cash adjustments to Net income.
  • Quest Diagnostics other non-cash items for the quarter ending March 31, 2025 were $30M, a 500% increase year-over-year.
  • Quest Diagnostics other non-cash items for the twelve months ending March 31, 2025 were $205M, a 166.23% increase year-over-year.
  • Quest Diagnostics annual other non-cash items for 2024 were $0.106B, a 265.52% increase from 2023.
  • Quest Diagnostics annual other non-cash items for 2023 were $0.029B, a 64.2% decline from 2022.
  • Quest Diagnostics annual other non-cash items for 2022 were $0.081B, a 128.13% decline from 2021.
Quest Diagnostics Annual Other Non-Cash Items
(Millions of US $)
2024 $106
2023 $29
2022 $81
2021 $-288
2020 $201
2019 $12
2018 $146
2017 $98
2016 $38
2015 $133
2014 $370
2013 $-161
2012 $408
2011 $613
2010 $326
2009 $474
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.255B $9.872B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Encompass Health (EHC) United States $12.022B 25.49
DaVita (DVA) United States $10.562B 14.85
Chemed (CHE) United States $8.098B 25.45
Elanco Animal Health (ELAN) United States $6.397B 13.70
Option Care Health (OPCH) United States $5.206B 23.20
RadNet (RDNT) United States $4.527B 287.33
Amedisys (AMED) United States $3.100B 20.85
LifeStance Health (LFST) United States $2.232B 0.00
Addus HomeCare (ADUS) United States $1.992B 21.87
Astrana Health (ASTH) United States $1.486B 36.81
U.S Physical Therapy (USPH) United States $1.174B 30.29
Aveanna Healthcare Holdings (AVAH) United States $1.135B 64.67
Pennant (PNTG) United States $1.010B 37.10
Atai Life Sciences (ATAI) Germany $0.286B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00